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Abstract
Objective
To investigate the implications of low and moderate preoperative alcohol consumption on
postoperative mortality and morbidity after primary hip and knee arthroplasty.
Methods
A total of 30,799 patients who underwent primary hip or knee arthroplasty between January
1st, 2005 and October 8th, 2011 with information on preoperative alcohol consumption (0
grams of pure alcohol/week, >0–168 g/week, >168–252 g/week, and >252 g/week) were
identified through the Danish Anesthesia Database. The 90-day and 1-year risks of mortality
(primary outcomes), 1-year risk of prosthetic infection, and 30-day risks of cardiovascular
disease and deep venous thrombosis (secondary outcomes) were estimated by Cox regres-
sion analysis.
Results
We identified 285 (0.9%) deaths within the first 90 days and 694 (2.3%) within the first
year. Within the first 30 days, 209 (0.7%) and 270 (0.9%) patients had acquired cardio-
vascular disease and deep venous thrombosis, respectively, and 514 (1.7%) patients
developed prosthetic infection within the first year. The adjusted mortality models yielded
hazard ratios of 0.55 (95% confidence interval [CI] 0.41 to 0.74) at 90 days and 0.61 (95%
CI 0.51 to 0.73) at 1 year for the group consuming >0–168 g/week when compared to
abstainers. Adjusted hazard ratios showed that the group consuming >0–168 g/week had
a 0.91 (95% CI 0.75 to 1.11) risk of prosthetic infection, 0.68 (95% CI 0.50 to 0.92) risk of
cardiovascular disease and 0.88 (95% CI 0.67 to 1.15) risk of deep venous thrombosis
when compared to abstainers.
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Conclusions
This study demonstrates that low-to-moderate alcohol consumption prior to primary hip or
knee arthroplasty is associated with lower risks of mortality at both 90 days and 1 year after
surgery and of cardiovascular disease after 30 days. More research from longitudinal stud-
ies is needed to identify specific causal relations and explanations.
Introduction
Excessive use of alcohol prior to surgery is an established risk factor for postoperative mortality
and morbidity [1]. Most patients referred for elective surgery have a low or moderate use of
alcohol [2], but the importance of this level of consumption on adverse postoperative outcomes
is uncertain [3]. In many studies, abstainers are grouped together with low and moderate alco-
hol consumers, and several studies have investigated a combination of multiple surgery popula-
tions with uneven risk profiles [3]. A recent meta-analysis by Eliasen et al. (2013) concluded
that preoperative alcohol consumption was associated with an increased risk of postoperative
morbidity but not with postoperative mortality [3]. Furthermore, low-to-moderate consump-
tion did not seem to be associated with postoperative complications, but the few existing studies
that included this consumption group reported lower mortality risks when this group was com-
pared to abstainers [3]. However, in addition to the general tendency of grouping abstainers
together with low-to-moderate consumers, Eliasen et al. (2013) pinpoints that several studies
tend to lack sufficient confounder adjustment [3]. This gap in knowledge regarding postopera-
tive mortality and morbidity related to a low-to-moderate alcohol consumption may lead to
unjustified advice to patients. More knowledge on the subject is essential to improve preopera-
tive risk management.
To address the importance of preoperative alcohol consumption in the prognosis of adverse
postoperative outcomes without excessive confounding by multiple risk profiles, we selected
an orthopedic population that underwent elective primary hip or knee arthroplasty that have
received little attention in previous research [3,4]. Therefore, the aim of this study was to inves-
tigate the relationship between preoperative alcohol consumption, with a focus on abstainers
and low-to-moderate consumers, and the risks of postoperative mortality and morbidity follow-
ing primary hip or knee arthroplasty. Based on the existing knowledge, we expected a decreased
risk of mortality among low-to-moderate alcohol consumers when compared to abstainers and
a lack of risk difference between these groups regarding postoperative morbidity.
Methods
Data sources
The Danish Anesthesia Database in conjunction with several other nationwide registers was
used to conduct this large, register-based cohort study [5,6]. The Danish Anesthesia Database
is a clinical quality database that prospectively and consecutively collects anesthetic informa-
tion on patients’ perioperative periods from Danish departments of anesthesia [7]. The data-
base covered fourteen departments in 2005 and was later increased to a coverage ratio of 70%
and 40 departments [7,8]. The Danish Anesthesia Database allowed the identification of date
and type of surgery (Nordic Medico Statistical Committee (NOMESCO) classification of surgi-
cal procedures) [9], weekly alcohol consumption, smoking status, American Society of Anes-
thesiologists physical status classification [10], height and weight. Health professionals collect
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OmDS/organisation/TelefonbogOrg.aspx?
kontor=13&tlfbogsort=sektion or the Danish Data
Protection Agency: https://www.datatilsynet.dk/
english/the-danish-data-protection-agency/
contact/. Additionally, Prof. Christian Torp-
Pedersen (torp@rn.dk) can be contacted in order
to access data which will need to be done in
collaboration.
Funding: The authors received no specific funding
for this work.
Competing interests: The authors have declared
that no competing interests exist.
the information through a uniform questionnaire whose completion is required prior to surgi-
cal procedures in Denmark. The National Patient Register allowed the identification of birth
year and sex in addition to pre- and postoperative admission diagnoses (International Classifi-
cation of Diseases (ICD) 8th and 10th revision) from all hospitals in Denmark [5,6,11]. Survival
status was identified through The Register of Causes of Death, in which all deaths in Denmark
are registered [12]. Data on preoperative medication use were identified though The National
Prescription Registry, where all claimed prescriptions from Danish pharmacies are registered
with World Health Organization (WHO)’s Anatomical Therapeutic Chemical (ATC) classifi-
cation codes [13,14]. Data on annual household income were accessible via The Danish
Income Statistics Register [6]. Data were accessed through Statistics Denmark and were com-
bined across registries through individual linkage using Danish Civil Personal Register num-
bers [5,15].
Study population
We included all patients who were reported as having undergone primary hip or knee arthro-
plasty (NOMESCO: KNFB or KNGB) in Denmark from January 1th, 2005 to October 8th, 2011
through the Danish Anesthesia Database. We only included the first entry of either primary
hip or knee arthroplasty for each patient. Subsequently, only procedures coded as elective were
included due to the very different risk profiles in acute operations [16,17]. Due to general risk
differences, only patients who were over 45 years old [18,19] and who had an American Soci-
ety of Anesthesiologists physical status classification and a Charlson Comorbidity Index of less
than 4 were included to improve internal comparability [16,20].
Covariates
Anesthesiologists were ticking boxes with categorical data on alcohol consumption on a form,
and this information is directly coded into the registry.
Information on alcohol consumption was taken directly from the registry (unit) and was
transformed into grams of pure alcohol (one unit corresponds to 12 grams of pure alcohol in
Denmark): 0 grams of pure alcohol/week (abstention), >0–168 g/week (low-to-moderate con-
sumption), >168–252 g/week (high consumption), or >252 g/week (excessive consumption).
In addition to age and sex, other potential confounders were identified, including smoking sta-
tus [21,22], socioeconomic status [23–25], preoperative comorbidity status [16,20,23], and
body mass index (BMI) [26]. Age was divided into quartiles: 45 to 62.4 years, 62.4 to 69.2
years, 69.3 to 76.2 years and over 76.2 years. Smoking status was recorded as smoker, former
smoker, non-smoker, or not asked. Many alcohol consumers are smokers [27]. Consequently,
we grouped patients not asked about their smoking status as current smokers, as information
on smoking status was lacking for a relatively large group of excessive alcohol consumers. Sen-
sitivity analyses were conducted to control the robustness of this decision. Annual household
income the year preceding surgery was divided into quartiles and was used as a proxy for
socioeconomic status. Preoperative hospital diagnoses defined the Charlson Comorbidity
Index [28]. The Charlson Comorbidity Index and American Society of Anesthesiologists phys-
ical status classification represented the preoperative comorbidity status. BMI was calculated
using information on height and weight and was categorized according to the WHO classifica-
tion [29]. Patients with BMIs above 60 or below 13 were categorized as missing to exclude pos-
sible incorrect entries of height and weight. Hip or knee arthroplasty are frequent in patients
with rheumatoid arthritis, and these patients may have received treatment with methotrexate,
which requires restriction of alcohol consumption [30]. Therefore, information on preopera-
tive use of methotrexate (ATC code: L01BA01, L04AX03) was included.
Preoperative alcohol consumption and postoperative outcomes in arthroplasty patients
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Outcomes
The follow-up periods for all outcomes were set according to the European Perioperative Clin-
ical Outcome (EPCO) definitions [31]. The 90-day and 1-year risks of mortality were set as pri-
mary outcomes. Prosthetic infection (ICD-10: T845-847), cardiovascular disease (ICD-10: I63-
64, G458-459, I21-22) and deep venous thrombosis (ICD-10: I801-803, I809) were set as sec-
ondary outcomes, as these postoperative complications have especially been associated with
patients with high or excessive alcohol consumption or alcohol abuse [1,4,32–34]. To comply
with the EPCO guidelines, the 1-year risk of prosthetic infection and 30-day risks of cardiovas-
cular disease and deep venous thrombosis were examined. Cases and dates of postoperative
readmissions caused by these diagnoses were identified. Participants were followed until the
date of event or December 31, 2012.
Statistical analysis
Differences in baseline characteristics between alcohol consumption levels were tested with
Pearson’s chi-squared test. The Kaplan Meier survival function was used to estimate 1-year
survival curves and cumulative death rates for different levels of alcohol consumption. The
Aalen-Johansen estimator was used to estimate the cumulative incidence of cardiovascular
disease and deep venous thrombosis 30 days postoperative and 1 year after surgery for pros-
thetic infection. Cox Proportional Hazards Regression was used to estimate unadjusted and
adjusted hazard ratios (HRs) with corresponding 95% confidence intervals (CIs). All results
were based on a complete case analysis. Analyses were adjusted for age, sex, smoking status,
BMI, annual income, Charlson Comorbidity Index, American Society of Anesthesiologists
physical status classification, operation type and preoperative use of methotrexate. The pro-
portional hazards assumption was validated with Schoenfeldt-residuals [35]. The Charlson
Comorbidity Index did not meet this assumption, and adjusted models were stratified
according to this variable. Interactions between alcohol consumption and smoking status,
alcohol consumption and sex, alcohol consumption and age, and alcohol consumption and
comorbidity status were examined. No statistical significant interactions were detected. In
subgroups defined by age-quartiles (45 to 62.4 years, 62.5 to 69.2 years, 69.3 to 76.2 years
and over 76.2 years) we furthermore conducted Cox regression analyses for 1-year mortality
to identify possible risk-differences in age groups. The subgroup analyses were adjusted for
sex, smoking status, BMI, annual income, Charlson Comorbidity Index, American Society
of Anesthesiologists physical status classification, operation type and preoperative use of
methotrexate. Sensitivity analyses were conducted to identify possible changes in the risk
estimates when patients not asked about their smoking status were grouped as non-smok-
ers. An additional sensitivity analysis was conducted when abstaining patients not asked
about their smoking status were grouped as non-smokers while the remaining patients not
asked were grouped as smokers. All significance was set at P<0.05.
The SAS statistical software package for Windows, version 9.4 (SAS Institute, Cary, NC,
USA), was used for data management, and the R statistical software package, version 3.0.2 (R
Development Core Team), was used for statistical analyses.
Ethics
Use of data for this study was approved by the Danish Data Protection Agency (No. 2007-41-
1667). In Denmark register-based studies do not require ethical approval or obtained written
informed consent [36].
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Results
Participants
There were 48,817 registrations of primary hip or knee arthroplasty in the study period.
When only first operations were included, 42,904 patients were eligible for the study. Of
these, 5,770 (13.5%) operations were registered as acute, 1,233 (2.9%) patients were under
45 years, 169 (0.4%) had an American Society of Anesthesiologists physical status classifica-
tion of more than 3 and 170 (0.4%) had a Charlson Comorbidity Index of more than 3, any
of which led to their exclusion. Of the 35,562 remaining patients, 4,015 (11.3%) were miss-
ing data on alcohol consumption, 407 (1.1%) on BMI, 324 (0.9%) on American Society of
Anesthesiologists physical status classification, 10 (0.03%) on annual income, and five
(0.01%) on smoking status and were therefore excluded from further analyses. Two (0.01%)
patients were additionally excluded due to incorrect entries of dates. These exclusions
resulted in a final study population of 30,799 patients.
The final study population consisted of 13,525 (43.9%) abstainers, 12,853 (41.7%) low-to-
moderate consumers (>0–168 g/week), 1,958 (6.4%) high consumers (>168–252 g/week), and
2,463 (8.0%) excessive consumers (>252 g/week). The baseline characteristics for the con-
sumption groups are presented in Table 1.
Abstainers were typically older, female and non-smoking and had more comorbidities than
alcohol consumers, as indicated by higher scores on the Charlson Comorbidity Index and the
American Society of Anesthesiologists physical status classification (Table 1). Abstainers were
also most often obese. Low-to-moderate consumers were typically younger, non-smokers,
overweight, and had fewer comorbidities than abstainers. Within the group of excessive alco-
hol consumption, 40.1% were not asked about their smoking status. A graphic overview of the
alcohol consumption distribution is presented in a histogram in S1 Fig.
Postoperative mortality
During the first 90 days, a total of 285 (0.9%) deaths were identified. The number increased to
694 (2.3%) after one year (Table 2). Abstainers had the highest absolute and relative numbers
of deaths at both time points, while low-to-moderate consumers had the lowest relative num-
ber of all consumption groups. A high relative number of deaths was also seen among excessive
consumers. However, a low absolute numbers of deaths were detected among high and exces-
sive consumers due to their smaller group sizes.
The Kaplan-Meier survival function showed that low-to-moderate consumers had better
survival rates during the first year after surgery (Fig 1). The largest difference between low-to-
moderate consumers and the other groups was seen during the first 30 days after surgery, as
the survival rates in all other groups decreased notably. As seen in Table 2, abstainers had the
poorest survival 1 year after surgery.
Unadjusted models detected significantly lower risks of mortality after both 90 days (HR
0.43, 95% CI 0.32 to 0.56) and 1 year (HR 0.49, 95% CI 0.41 to 0.58) among low-to-moderate
consumers when compared to abstainers (Fig 2). After adjusting for confounders, attenuation
of the association between these groups was noted; yet, significantly lower risks for both
90-day (HR 0.55, 95% CI 0.41 to 0.74) and 1-year mortality (HR 0.61, 95% CI 0.51 to 0.73)
were observed among low-to-moderate consumers. No other risk estimate differed signifi-
cantly from abstainers in any adjusted model. Results of the supplementary analysis of 1-year
mortality stratified by age-quartiles did not reveal significant differing risk estimates across
consumption groups (S1 Table).
Preoperative alcohol consumption and postoperative outcomes in arthroplasty patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0173083 March 17, 2017 5 / 16
Table 1. Baseline characteristics (n (%)) among 30,799 patients undergoing primary hip or knee arthroplasty in the period from January 2005 to
October 2011, presented according to alcohol consumption levels and in total.
Abstentiona(n = 13,525) Low-to-
moderatea(n = 12,853)
Higha(n = 1,958) Excessivea(n = 2,463) Total(n = 30,799) P valueb
Age
45 to 62.4 3,113 (23.0) 3,265 (25.4) 566 (28.9) 756 (30.7) 7,700 (25.0)
62.5 to 69.2 3,024 (22.4) 3,343 (26.0) 636 (32.5) 695 (28.2) 7,698 (25.0)
69.3 to 76.2 3,226 (23.9) 3,444 (26.8) 489 (25.0) 543 (22.1) 7,702 (25.0)
Over 76.2 4,162 (30.8) 2,801 (21.8) 267 (13.6) 469 (19.0) 7,699 (25.0) <0.0001
Gender
Women 9,665 (71.5) 7,145 (55.6) 475 (24.3) 1,017 (41.3) 18,302 (59.4)
Men 3,860 (28.5) 5,708 (44.4) 1,483 (75.7) 1,446 (58.7) 12,497 (40.6) <0.0001
Surgery type
Hip arthroplasty 7,076 (52.3) 7,020 (54.6) 1,085 (55.4) 1,246 (50.6) 16,427 (53.3)
Knee arthroplasty 6,449 (47.7) 5,833 (45.4) 873 (44.6) 1,217 (49.4) 14,372 (46.7) <0.0001
Smoking status
Current 2,078 (15.4) 2,365 (18.4) 512 (26.1) 505 (20.5) 5,460 (17.7)
Former 2,267 (16.8) 3,763 (29.3) 629 (32.1) 461 (18.7) 7,120 (23.1)
Non-smoker 7,445 (55.0) 6,129 (47.7) 725 (37.0) 510 (20.7) 14,809 (48.1)
Not asked 1,735 (12.8) 596 (4.6) 92 (4.7) 987 (40.1) 3,410 (11.1) <0.0001
BMI
Underweight 262 (1.9) 133 (1.0) 19 (1.0) 33 (1.3) 447 (1.5)
Normal weight 3,995 (29.5) 3,967 (30.9) 534 (27.3) 673 (27.3) 9,169 (29.8)
Overweight 4,914 (36.3) 5,304 (41.3) 886 (45.3) 998 (40.5) 12,102 (39.3)
Obese 4,354 (32.2) 3,449 (26.8) 519 (26.5) 759 (30.8) 9,081 (29.5) <0.0001
Annual incomec
210 4,423 (32.7) 2,458 (19.1) 278 (14.2) 598 (24.3) 7,757 (25.2)
>210 to 300 3,590 (26.5) 3,084 (24.0) 346 (17.7) 501 (20.3) 7,521 (24.4)
>300 to 480 3,017 (22.3) 3,499 (27.2) 561 (28.7) 658 (26.7) 7,735 (25.1)
>480 2,495 (18.4) 3,812 (29.7) 773 (39.5) 706 (28.7) 7,786 (25.3) <0.0001
CCId
0 11,976 (88.5) 11,788 (91.7) 1,783 (91.1) 2,257 (91.6) 27,804 (90.3)
1 1,073 (7.9) 718 (5.6) 127 (6.5) 142 (5.8) 2,060 (6.7)
2 314 (2.3) 252 (2.0) 38 (1.9) 46 (1.9) 650 (2.1)
3 162 (1.2) 95 (0.7) 10 (0.5) 18 (0.7) 285 (0.9) <0.0001
ASA
classificatione
1 2,680 (19.8) 3,383 (26.3) 528 (27.0) 519 (21.1) 7,110 (23.1)
2 8,694 (64.3) 7,919 (61.6) 1,191 (60.8) 1,588 (64.5) 19,392 (63.0)
3 2,151 (15.9) 1,551 (12.1) 239 (12.2) 356 (14.5) 4,297 (14.0) <0.0001
Methotrexate 488 (3.6) 348 (2.7) 50 (2.6) 61 (2.5) 947 (3.1) <0.0001
a Abstention = 0 g/week. Low-to-moderate consumption = >0–168 g/week. High consumption = >168–252 g/week. Excessive consumption = >252 g/week.
b Pearson’s chi-squared test
c Annual income is presented in 1000 DKK (1000 DKK corresponds to approx. € 134 Euros)
d Charlson Comorbidity Index
e American Society of Anesthesiologists physical status classification
https://doi.org/10.1371/journal.pone.0173083.t001
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Postoperative morbidity
In total, we identified 209 cases of cardiovascular disease and 270 cases of deep venous throm-
bosis during the first 30 days after surgery. A total of 514 patients acquired prosthetic infection
during the 1-year follow-up (Table 3). A slightly higher cumulative incidence proportion of
Table 2. Number (%) of cases in the primary outcomes among 30,799 patients undergoing primary hip or knee arthroplasty, presented according
to alcohol consumption levels and in total.
Abstentiona Low-to-moderatea Higha Excessivea Total P valueb
Mortality, 90 days 170 (1.3) 69 (0.5) 16 (0.8) 30 (1.2) 285 (0.9) <0.001
Mortality, 1 year 407 (3.0) 191 (1.5) 36 (1.8) 60 (2.4) 694 (2.3) <0.001
a Abstention = 0 g/week, low-to-moderate consumption = >0–168 g/week, high consumption = >168–252 g/week, excessive consumption = >252 g/week
b Pearson’s chi-squared test
https://doi.org/10.1371/journal.pone.0173083.t002
Fig 1. 1-year survival rates after primary hip or knee arthroplasty plotted by the Kaplan Meier survival function. The survival rates of 30,799 patients,
according to different levels of preoperative alcohol consumption during the first postoperative year after primary hip or knee arthroplasty in Denmark.
https://doi.org/10.1371/journal.pone.0173083.g001
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Fig 2. Postoperative mortality at 90 days and 1 year. Unadjusted and adjusted 90-day and 1-year risks of mortality among 30,799
arthroplasty patients with different preoperative levels of alcohol consumption.
https://doi.org/10.1371/journal.pone.0173083.g002
Table 3. Number of cases (n) and cumulative incidence ((%), [95% Confidence Intervals (CI)]) in the secondary outcomes among 30,799 patients
undergoing primary hip or knee arthroplasty, presented according to alcohol consumption levels and in total.
Abstentiona Low-to-
moderatea
Higha Excessivea Total
Cardiovascular disease, 30 days. Number of cases, Cumulative
incidence ((%), [95% CI])
114, 0.8 [0.7 to
1.0]
69, 0.5 [0.4 to
0.7]
14, 0.7 [0.3 to
1.1]
12, 0.5 [0.2 to
0.8]
209, 0.7 [0.6
to 0.8]
Deep venous thrombosis, 30 days. Number of cases,
Cumulative incidence ((%), [95% CI])
126, 0.9 [0.8 to
1.1]
100, 0.8 [0.6 to
0.9]
13, 0.7 [0.3 to
1.0]
31, 1.3 [0.8 to
1.7]
270, 0.9 [0.8
to 1.0]
Prosthetic infection, 1 year. Number of cases, Cumulative
incidence ((%), [95% CI])
229, 1.7 [1.5 to
1.9]
184, 1.4 [1.2 to
1.6]
51, 2.6 [1.9 to
3.3]
50, 2.0 [1.5 to
2.6]
514, 1.7 [1.5
to 1.8]
a Abstention = 0 g/week, low-to-moderate consumption = >0–168 g/week, high consumption = >168–252 g/week, excessive consumption = >252 g/week
https://doi.org/10.1371/journal.pone.0173083.t003
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cardiovascular diseases 30 days after surgery was observed among abstainers (0.8%, [95% CI,
0.7% to 1.0%]), while deep venous thrombosis was most frequent among excessive consumers
(1.3%, [95% CI, 0.8% to 1.7%]). High consumers had the highest cumulative incidence propor-
tion of prosthetic infection after 1 year (2.6%, [95% CI, 1.9% to 3.3%]).
The unadjusted risk estimates observed in all alcohol consumption groups differed gener-
ally more from abstainers than the adjusted risk estimates (Fig 3). The adjusted risk of cardio-
vascular disease after 30 days was significantly lower among patients with low-to-moderate
consumption than among abstainers (HR 0.68, 95% CI 0.50 to 0.92). Other endpoints did not
reveal any significant risk differences between these groups. The adjusted estimates showed an
increased risk of prosthetic infection for high consumers compared to abstainers (HR 1.55,
95% CI 1.13 to 2.13).
Sensitivity analysis
Postoperative mortality. Compared to the adjusted results, no notable differences were
identified in any model when patients not asked about their smoking status were grouped as
non-smokers (Sensitivity analysis 1, S2 Fig) or when abstainers not asked about smoking status
were grouped as non-smokers and the remaining patients not asked about their smoking sta-
tus were grouped as smokers (Sensitivity analysis 2, S2 Fig). A slight increase in the risk attrib-
uted to excessive consumers in 1-year mortality was observed in Sensitivity analysis 1, but no
significant risk difference was seen when compared to abstainers.
Postoperative morbidity. Similarly, the risk estimates seen in the sensitivity analyses
regarding morbidity did not differ notably from the originally adjusted results; consequently,
no change in the direction of any result was detected (S3 Fig).
Discussion
The main findings of this study were that arthroplasty patients with low-to-moderate preoper-
ative alcohol consumption had lower risks of both 90-day and 1-year mortality when com-
pared to patients who abstained from alcohol prior to surgery. Additionally, low-to-moderate
consumers were associated with a lower risk of cardiovascular disease after 30 days compared
to abstainers. These findings were observed in both unadjusted and adjusted models. There
were no other differences in other endpoints between abstainers and low-to-moderate con-
sumers, but when comparing abstainers to high consumers, a higher risk of prosthetic infec-
tion within the first year after surgery was observed among high consumers.
Our results regarding postoperative mortality corresponded to our hypothesis, as we
observed a significantly decreased risk of postoperative mortality among low-to-moderate
consumers compared to abstainers. However, this decreased risk was not completely recapitu-
lated for postoperative morbidity. We expected no between-group difference, which was the
case for deep venous thrombosis and prosthetic infection, but low-to-moderate consumers
had a significantly lower risk of cardiovascular complications within 30 days after surgery. Our
findings may suggest that low-to-moderate preoperative alcohol consumption reduces the risk
of postoperative mortality, but the nature of the study makes it impossible to imply causality.
This result may be driven by other aspects of health that are also associated with low-to-mod-
erate alcohol consumption.
A range of postoperative complications has been studied in relation to different levels of
alcohol consumption, but few studies have focused on the risk of these complications in rela-
tion to low-to-moderate preoperative consumption compared to complete abstention [3].
Decreased risks of several postoperative complications among low and moderate alcohol con-
sumers when compared to abstainers has been reported, but there were no significant
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Fig 3. Risk of postoperative morbidity. Unadjusted and adjusted risks of prosthetic infection after 1 year and cardiovascular disease and deep venous
thrombosis after 30 days among 30,799 arthroplasty patients with different preoperative levels of alcohol consumption.
https://doi.org/10.1371/journal.pone.0173083.g003
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between-group differences [3]. Similarly, we observed decreased risks of all postoperative com-
plications for low-to-moderate consumers when compared to abstainers, but only in the case
of cardiovascular disease did the estimates differ significantly between these groups. Other
studies have investigated the risk of adverse postoperative events among patients, yet with dif-
fering alcohol consumption thresholds. Among these, Jørgensen et al. compared consumption
of more than 168 g/week with a lower consumption level and did not detect any risk differ-
ences between these groups in terms of general or alcohol-specific readmission rates after hip
or knee arthroplasty [37]. However, Nath et al. detected increased risks of certain postoperative
complications associated with consumption of more than approximately 200 g/week when
compared to a lower consumption level but did not find a significantly increased risk of post-
operative mortality [33]. The relationship between alcohol consumption and adverse postoper-
ative events seems to differ depending on outcome, level of alcohol consumption, surgical
populations, and several other potential factors. The general inconsistency of the findings
observed in both our study and the literature suggests that this relationship may be highly
complex.
Although the relationships between the specific levels of alcohol consumption and postop-
erative mortality and morbidity have been insufficiently studied, it may be suggested that low-
to-moderate consumers have a lower risk of cardiovascular disease compared to abstainers, as
low or moderate alcohol consumption may protect against adverse cardiovascular events [38].
This mechanism may also be a contributing factor for the observation of lower mortality risk
among low-to-moderate consumers because cardiovascular diseases are reported to be a fre-
quent cause of death after hip arthroplasty [39].
We did find an increased risk of prosthetic infection among high consumers compared to
abstainers, which can potentially be linked to several abnormalities in the immune responses
of chronic alcohol users that make them more susceptible to infections [40–42]. However, it is
noteworthy that we did not detect any differences between abstainers and excessive consumers
in our study, as this group included all consumption above 252 g/week. In contrast, a previous
review of the literature detected increased risks of postoperative morbidity, with odds ratios
ranging from 3.1 to 26.6 among alcohol abusers consuming at least 60 grams of alcohol per
day [42], which corresponds to 420 g/week. The lack of difference in risk between abstainers
and excessive consumers may indicate that heavy alcohol abusers in this study had consump-
tion close to the lower limit. Most likely, true heavy consumers might not be candidates for
surgery.
Strengths and limitations
Large-scale observational study may often be the most suitable approach to detect late adverse
outcomes in clinical practice [43]. The Danish Civil Personal Register number provides a
unique opportunity to link data from several national registries, which enabled us to combine
information on a large population at an individual level and ensured minimal loss to follow-
up. Additionally, the use of individual pre- and postoperative health records that cover an
extensive amount of time strengthens the results.
Another strength is the use of data on preoperative alcohol consumption collected by hospi-
tal staff shortly before surgery. Patients would generally be informed about possible interac-
tions between alcohol and anesthetic drugs and may therefore be inclined to provide more
accurate information on alcohol consumption than is given in general population studies. Fur-
thermore, comprehensively adjusted risk estimates added strength to our study. Both the
Charlson Comorbidity Index and the American Society of Anesthesiologists physical status
classification were included to account for preoperative comorbidity status in the adjusted
Preoperative alcohol consumption and postoperative outcomes in arthroplasty patients
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models. The Charlson Comorbidity Index addresses the individual preoperative history of
comorbidities, and the American Society of Anesthesiologists physical status classification
describes the physical status of the patient immediately prior to surgery. The American Society
of Anesthesiologists physical status classification and the Charlson Comorbidity Index may
predict different types of postoperative complications in patients undergoing spinal surgery
[44], which supports the inclusion of both measures.
Some limitations are related to this study. First, the consumption groups differed signifi-
cantly in all baseline characteristics, which may allow residual confounding in spite of con-
founder adjustment. Other unobserved confounding might also remain unadjusted. Second,
as patients with excessive alcohol consumption are generally recommended to comply with a
preoperative period of abstinence, some patients designated as abstainers in our study may
actually be former excessive consumers. Data describing any former history of alcohol con-
sumption could not be obtained. Consequently, we were not able to determine this specific
proportion of patients or its implications. Preoperative abstinence may also be a result of poor
state of health or medication use, as proposed by the sick-quitter hypothesis [19]. Using
abstainers as reference might therefore lead to abstainer bias where the protective association
seen in low risk drinkers are overestimated when compared to abstainers [45]. This hypothesis
might apply to some abstainers in our study, as this group showed larger proportions of Amer-
ican Society of Anesthesiologists physical status classification of 3, Charlson Index of 3, and
methotrexate use at baseline. However, as recommended by Rehm et al. [45], this possibility
was presumably addressed through confounder adjustment.
Third, although the use of administrative databases reduces the risk of missing patients and
drop-out during follow-up, risks of inadequate registration, misclassification, and insufficient
encoding still exist [4,46]. When compared to other sources of data, certain diagnoses appear
to be underreported in the Danish National Patient Register [5,47]. Furthermore, diagnoses
are only registered in the Danish National Patient Register when patients are hospitalized.
Underreporting of diagnoses may result in insufficient comorbidity adjustment and underesti-
mated risks of postoperative morbidity. Furthermore, underreporting is a common problem
with self-reported alcohol consumption due to impression management or recall bias [48,49].
Underreported consumption can result in misclassification and is most likely to affect younger
and low-risk drinkers [50]. Some underestimation might therefore be associated to low-to-
moderate consumers in our study. However, as our study population is 45 years or older and
as data on alcohol consumption are collected prior to undergoing surgery, underreporting
may be of less significance than when studying younger populations. Finally, 40.1% of the
patients who reported excessive alcohol consumption were not asked about smoking status.
There are reasons to believe that the true number of smokers within this group may be higher
than reported because alcohol consumers are often smokers [27]. Patients not asked about
their smoking status were therefore categorized as smokers and sensitivity analyses were con-
ducted to test this assumption. These analyses did not reveal any significant changes in any
risk estimate when this group was handled as non-smokers or when only abstainers were han-
dled as non-smokers. This indicates that our main results were robust.
Implications
This study contributes to the limited knowledge on the relationship between low-to-moderate
alcohol consumption or complete abstention and postoperative mortality and morbidity in an
orthopedic population. To identify the best approach for addressing alcohol-related risks in
surgical populations, it is important to know whether preoperative abstinence is better than
modest consumption [51]. Our study may indicate that low-to-moderate consumers have
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better survival rates at 90 days and 1 year after primary hip or knee arthroplasty than complete
abstainers. Moreover, a lower risk of cardiovascular disease after 30 days was associated with
low-to-moderate consumption. Our results indicate that a consumption level greater than 168
g/week may be associated with increased risks of adverse outcomes, which supports the preop-
erative guidance physicians provide to patients on alcohol consumption prior to primary hip
or knee arthroplasty. However, current preoperative alcohol recommendations address mainly
patients who are excessive consumers, which suggests a preoperative period of abstention [1].
Our findings could be of relevance in a discussion on whether these recommendations should
be revised, taking into account that a low level of alcohol consumption prior to hip or knee
arthroplasty may not be associated to an increased risk of postoperative mortality, cardiovas-
cular disease, deep venous thrombosis or prosthetic infection. Nevertheless, randomized trials
are needed to confirm our results and to increase our understanding of causal mechanisms.
Furthermore, additional research is needed in conjunction with data on former alcohol con-
sumption so that the patients who may benefit from such recommendations could be identi-
fied more precisely. Finally, future research should investigate whether our findings are
applicable to other surgical populations.
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